Replies to post #39412 on ProText Mobility Inc (TXTM)

[Lucky/Louis]

Squeezed operating margins are a good point. I see value in the chemistry; i.e. marrying up phytofare with cannabis. I would expect to see further clinical trials once the licensing goes through. I could be way off however; I am down 35% on this position.

[One_Life83]

I agree but TXTM would be the only company in South Africa with such a license. Also add value of the other products involved into the equation, should overall increase market value IMO.